The treatment of hispidulin in AGS human gastric adenocarcinoma cell line could reduce cyclooxygenase-2 (COX-2) expression while keeping a high expression of nonsteroidal-anti-inflammatory-drug-(NSAID-) activated gene-1 (NAG-1). Here, PTGS2 is linked to gastric adenocarcinoma.